ISDA

Entry Detail

PDB ID:

2XBV

Keywords:

BLOOD CLOTTING

Title:

Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor

Biological Source:

Source Organism:

HOMO SAPIENS

Host Organism:

ESCHERICHIA COLI

PDB Version:

Deposition Date:

2010-04-15

Release Date:

2010-08-04

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.66 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 43 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:ACTIVATED FACTOR XA HEAVY CHAIN
Mutations:YES
Chain IDs:A
Chain Length:241
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF14670 EC:3.4.21.6

Protein Blast

Polymer Type:polypeptide(L)
Description:FACTOR X LIGHT CHAIN
Chain IDs:B (auth: L)
Chain Length:55
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF14670 EC:3.4.21.6

Ligand Molecules

XBV

Primary Citation

Discovery of a Factor Xa Inhibitor (3R,4R)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic Acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-{[2-Fluoro-4-(2-Oxo-2H-Pyridin-1-Yl)-Phenyl]-Amide} as a Clinical Candidate.

Anselm, L, Banner, D.W, Benz, J, Groebke Zbinden, K, Himber, J, Hilpert, H, Huber, W, Kuhn, B, Mary, J.L, Otteneder, M.B, Panday, N, Ricklin, F, Stahl, M, Thomi, S, Haap, W.Show

Bioorg.Med.Chem. 20 5313 ? (2010)

PMID: 20650636 DOI: 10.1016/J.BMCL.2010.06.126

Abstact

A series of (3R,4R)-pyrrolidine-3,4-dicarboxylic acid amides was investigated with respect to their factor Xa inhibitory activity, selectivity, pharmacokinetic properties, and ex vivo antithrombotic activity. The clinical candidate from this series, R1663, exhibits excellent selectivity against a panel of serine proteases and good pharmacokinetic properties in rats and monkeys. A Phase I clinical study with R1663 has been finalized.

Legend

Protein

Chemical

Disease

Primary Citation of related structures